Carmen Sanz, MD
Psychiatry · Bayamon, PRNPI 1669462024
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 32.9% of the total. Reporting peaked in 2019 at $1,142 and has fallen 97.9% since, to $25 in 2024. Among psychiatry clinicians in PR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 94 payments — averaging $20.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$633
- Sunovion Pharmaceuticals Inc.$459
- Lundbeck LLC$166
- Takeda Pharmaceuticals U.S.A., Inc.$155
- Shire North American Group Inc$81
- AbbVie$77
- plus $351 from 8 others
What the payments were for
- Food & beverage$1,923100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 24 | $633 |
| Sunovion Pharmaceuticals Inc. | 23 | $459 |
| Lundbeck LLC | 9 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $155 |
| Shire North American Group Inc | 4 | $81 |
| AbbVie(2 entities) | 5 | $77 |
| Tris Pharma Inc | 4 | $63 |
| Johnson & Johnson | 4 | $62 |
| Teva Pharmaceuticals USA, Inc. | 5 | $60 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Noven Therapeutics, LLC | 2 | $39 |
| Alkermes, Inc. | 2 | $34 |
| Merz Pharmaceuticals, LLC | 1 | $27 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LATUDA$125
- ABILIFY MAINTENA$122
How this compares
$1,923 in reported general payments places this provider in the 90th percentile of 312 psychiatry providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 94 | $178,524 |
| AustedoDeutetrabenazine | 33 | $153,310 |
| VraylarCariprazine Hcl | 49 | $71,550 |
| LatudaLurasidone Hcl | 18 | $38,463 |
| TrintellixVortioxetine Hydrobromide | 56 | $30,055 |
| NuedextaDextromethorphan Hbr/Quinidine | 12 | $18,082 |
| VyvanseLisdexamfetamine Dimesylate | 44 | $17,320 |
| Aripiprazole | 286 | $11,019 |
| Quetiapine Fumarate | 750 | $10,777 |
| Lamotrigine ErLamotrigine | 30 | $8,776 |
| Trazodone Hcl | 474 | $7,375 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 116 | $7,159 |
| Ambien CrZolpidem Tartrate | 12 | $7,051 |
| Lurasidone Hcl | 60 | $5,272 |
| Duloxetine Hcl | 354 | $5,199 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $633 | $178,52494 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $60 | $153,31033 claims |
| AbbVieVraylar | $77 | $71,55049 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $155 | $47,375100 claims |
| Sunovion Pharmaceuticals Inc.Latuda | $459 | $38,46318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 312 psychiatry providers in Puerto Rico.
Other psychiatry in Bayamon
- Eric Martinez ColonBayamon$2K
- Caroline ToroBayamon$2K
- Carmen J Brito MedinaBayamon$1K
- Mayra Abelleira MartinezBayamon$846
- Mary PerezBayamon$828
- Ileana FumeroSan Juan$128K
- Osvaldo CaroCaguas$101K
- Ivonne VicenteSan Juan$49K
- Jose Alonso AlonsoSan Juan$46K
- Maria ColladoJuncos$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.